跳至主要内容
临床试验/IRCT20201225049825N1
IRCT20201225049825N1招募中3 期

Assessment effect of Lactobacillus Reuteri (pyloshot) in H.pylori eradication with clarithromycin, amoxicillin and pantoprazole

Arak University of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • Have Helicobacter pylori
  • The patient volunteering to participate in the study,
  • Age 40-75 years
  • Be a resident of Arak.

排除标准

  • Having a metastatic cancer
  • Breastfeeding
  • History of failure of previous H.PYLORI treatment
  • Incomplete prescribed treatment regimen
  • Irregular use of medications and non-adherence to the prescribed treatment regimen
  • Previous gastrectomy
  • Suffering from incurable diseases
  • Patients with IHD
  • Chronic renal failure
  • GI bleeding
  • Concomitant use of tetracycline, quinolone, bisphosphonates, and levothyroxine (drug interaction)
  • People undergoing chemotherapy
  • Short Bowel Syndrome
  • Anemia and neutropenia
  • History of drug and food allergies
  • Hypercalcemia

研究者

相似试验